中国医药指南
中國醫藥指南
중국의약지남
CHINA MEDICINE GUIDE
2014年
15期
25-25,26
,共2页
急性心肌梗死%糖尿病患者%糖脂代谢
急性心肌梗死%糖尿病患者%糖脂代謝
급성심기경사%당뇨병환자%당지대사
Acute myocardial infarction%Diabetes%Lipid metabolism
目的:探究急性心肌梗死并发糖尿病患者糖脂代谢特点分析。方法选择107例急性心肌梗死患者,按是否患有糖尿病分为糖尿病组(54例)和非糖尿病组(53例),另选取同期健康体检者50例作为对照组,比较三组各血脂和血糖、糖化血红蛋白水平。结果合并糖尿病组和非糖尿病组各血脂指标比较无显著差异(P>0.05),但FPG和HbA1c显著高于非糖尿病组(P<0.05);合并糖尿病组各项指标均高于对照组(P<0.05),非糖尿病组在血脂各指标高于对照组(P<0.05),但两组TG和LDL-C无明显差异(P>0.05)。结论AMI并发糖尿病患者因血糖增高,存在明显的脂代谢异常特征,临床检测GHbA1c和血脂水平有利于监测病情。
目的:探究急性心肌梗死併髮糖尿病患者糖脂代謝特點分析。方法選擇107例急性心肌梗死患者,按是否患有糖尿病分為糖尿病組(54例)和非糖尿病組(53例),另選取同期健康體檢者50例作為對照組,比較三組各血脂和血糖、糖化血紅蛋白水平。結果閤併糖尿病組和非糖尿病組各血脂指標比較無顯著差異(P>0.05),但FPG和HbA1c顯著高于非糖尿病組(P<0.05);閤併糖尿病組各項指標均高于對照組(P<0.05),非糖尿病組在血脂各指標高于對照組(P<0.05),但兩組TG和LDL-C無明顯差異(P>0.05)。結論AMI併髮糖尿病患者因血糖增高,存在明顯的脂代謝異常特徵,臨床檢測GHbA1c和血脂水平有利于鑑測病情。
목적:탐구급성심기경사병발당뇨병환자당지대사특점분석。방법선택107례급성심기경사환자,안시부환유당뇨병분위당뇨병조(54례)화비당뇨병조(53례),령선취동기건강체검자50례작위대조조,비교삼조각혈지화혈당、당화혈홍단백수평。결과합병당뇨병조화비당뇨병조각혈지지표비교무현저차이(P>0.05),단FPG화HbA1c현저고우비당뇨병조(P<0.05);합병당뇨병조각항지표균고우대조조(P<0.05),비당뇨병조재혈지각지표고우대조조(P<0.05),단량조TG화LDL-C무명현차이(P>0.05)。결론AMI병발당뇨병환자인혈당증고,존재명현적지대사이상특정,림상검측GHbA1c화혈지수평유리우감측병정。
Objective To explore the acute myocardial infarction and diabetic patients with metabolic characteristics. Methods 107 cases of patients with acute myocardial infarction, according to whether the patients with diabetes were divided into diabetic group (54 cases) and non-diabetic group (53 cases), the other 50 cases of healthy people were selected as control group, compared three groups of blood lipid and blood glucose, glycosylated hemoglobin level. Results Diabetes group and non diabetes group lipid parameters showed no signiifcant difference (P>0.05), but FPG and HbA1c were signiifcantly higher than those in non diabetes mellitus group (P<0.05); diabetic groups were higher than the control group (P<0.05), non-diabetic group in lipids indexes higher than that of the control group (P<0.05), but no signiifcant difference between the two groups of TG and LDL-C (P>0.05). Conclusion AMI patients complicated with diabetes due to hyperglycemia, abnormal lipid metabolism characteristics, clinical detection of GHbA1c and blood lipid levels in favor of condition monitoring.